AGP Executive Report
Last update: 7 hours agoBladder Cancer Breakthrough: The EU’s CHMP has issued a positive opinion for Merck’s KEYTRUDA (pembrolizumab) plus Padcev (enfortumab vedotin) as perioperative and then adjuvant treatment for adults with resectable muscle-invasive bladder cancer, with a final European Commission decision expected in Q4 2026—covering EU plus Iceland, Liechtenstein and Norway. Royal Fashion Spotlight: Princess Charlene of Monaco returned to the Prince’s Palace in a muted neutral, ankle-length asymmetrical dress—one sleeveless arm and one sculptural sleeve—plus a small jeweled brooch, keeping the look modern and understated for the SENS network reception. New Treatment for Short Bowel Syndrome: Zealand Pharma received a positive CHMP opinion for Zeydovio (glepaglutide), a long-acting GLP-2 analog, marking a major European advance after more than a decade. Liechtenstein Travel Ideas: A fresh tourism round-up highlights how to explore Liechtenstein with minimal transit—Vaduz museums, castle views, vineyards and public art, plus mountain escape routes from Malbun. Sports Media in the Region: DAZN secured a new three-year NFL rights deal in Sweden, bringing up to seven games weekly (including NFL RedZone and Super Bowl) to Disney+ subscribers.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
